Data Bridge Market Research Has Added a New Market Report on "Global Hernia Mesh Devices Market – Analysis and Forecast 2012 – 2020"
Global Hernia Mesh Devices Market (By Product Type (Synthetic Mesh, Biologic Mesh), By Geography (North America, South America, Europe, Middle East & Africa, Asia-Pacific and Rest of the World).
Dallas, TX, February 09, 2016 --(PR.com)-- An Estimated around 11 million hernia repair surgeries were performed globally in 2014 and this number is projected to reach approximately 12.2 million by 2020, growing at the rate of 1.9% during the forecasted years 2015 to 2020. The report includes inguinal, umbilical, femoral, incisional and other kinds of hernia such as hiatal hernia. Inguinal hernia is proven to be the most common form of hernia and constituted around 55% of the total number of hernia surgeries performed in the year 2014, followed by incisional or ventral hernia surgeries with 16.8%. Femoral hernia occurring are very rare and only forms 1.5% of all hernia surgeries in 2014. Hernia surgeries requires to close or seal the weak spot present in the muscle through which intestinal content is protruding out. Presently, there are two treatment options available – hernia repair surgeries using sutures and hernia repair using mesh.
North America lead the market in terms of consumption of hernia repair mesh followed by Europe and APAC. In terms of revenue North America holds 45.9% of the market followed by Europe with 32.3% and APAC with 22.4%. APAC is expected to be the fastest growing market in the forecasted years due to huge number of hernia surgeries in India and China are still being operated using sutures and that scenario is expected to change due to better healthcare infrastructure and increasing awareness of minimally invasive surgeries in this region. The Global hernia mesh market is segmented into 2 mesh types Synthetic Mesh and Biologic Mesh. Synthetic mesh is the dominant product type in this market due to its affordability and incredible clinical acceptance from surgeons and the government. However, biologic mesh is quite new to the market, and is able to capture 6.2% of the market, in terms of volume in 2014. Due to the very expensive pricing of biologic meshes it holds almost 40% of the market in terms of value. The U.S. is the only country using biologic meshes very efficiently due the reimbursements being good and affordability not being an issue. The U.S. holds almost 58.0% of the biologic mesh market in terms of value in 2014.
The report further classifies Synthetic mesh into flat mesh and 3D mesh on the basis of structure of the mesh and into absorbable and non-absorbable based on the material the synthetic mesh is made of. Flat mesh is the most used mesh and accounts to more than 70% of the synthetic mesh segment in terms of market value. While the scenario of absorbable and non-absorbable synthetic meshes is varying from country to country based on the surgeons perspective in different geographies.
Some of the major players operating in this market are Medtronic (U.S.), C.R. Bard, Inc. (U.S.), Atrium (Sweden), W.L. Gore & Associates (Germany), Lifecell Corporation (U.S.) and B Braun Melsungen AG (Germany) among other players.
For free sample of the report
Mail at
sales@databridgemarketresearch.com
Or visit
http://databridgemarketresearch.com/reports/global-hernia-mesh-devices-market/
North America lead the market in terms of consumption of hernia repair mesh followed by Europe and APAC. In terms of revenue North America holds 45.9% of the market followed by Europe with 32.3% and APAC with 22.4%. APAC is expected to be the fastest growing market in the forecasted years due to huge number of hernia surgeries in India and China are still being operated using sutures and that scenario is expected to change due to better healthcare infrastructure and increasing awareness of minimally invasive surgeries in this region. The Global hernia mesh market is segmented into 2 mesh types Synthetic Mesh and Biologic Mesh. Synthetic mesh is the dominant product type in this market due to its affordability and incredible clinical acceptance from surgeons and the government. However, biologic mesh is quite new to the market, and is able to capture 6.2% of the market, in terms of volume in 2014. Due to the very expensive pricing of biologic meshes it holds almost 40% of the market in terms of value. The U.S. is the only country using biologic meshes very efficiently due the reimbursements being good and affordability not being an issue. The U.S. holds almost 58.0% of the biologic mesh market in terms of value in 2014.
The report further classifies Synthetic mesh into flat mesh and 3D mesh on the basis of structure of the mesh and into absorbable and non-absorbable based on the material the synthetic mesh is made of. Flat mesh is the most used mesh and accounts to more than 70% of the synthetic mesh segment in terms of market value. While the scenario of absorbable and non-absorbable synthetic meshes is varying from country to country based on the surgeons perspective in different geographies.
Some of the major players operating in this market are Medtronic (U.S.), C.R. Bard, Inc. (U.S.), Atrium (Sweden), W.L. Gore & Associates (Germany), Lifecell Corporation (U.S.) and B Braun Melsungen AG (Germany) among other players.
For free sample of the report
Mail at
sales@databridgemarketresearch.com
Or visit
http://databridgemarketresearch.com/reports/global-hernia-mesh-devices-market/
Contact
Data Bridge Market Research
Ravi Taneja
(+91) 9561452617
http://databridgemarketresearch.com/
Ravi Taneja
(+91) 9561452617
http://databridgemarketresearch.com/
Contact
Categories